Evaluate the Efficacy and Safety of Roxadustat for the Treatment of Anemia and Risks of Cardiovascular and Cerebrovascular Events in ESRD Newly Initiated Dialysis Patients

Condition:   Anemia in Incident Dialysis Patients Interventions:   Drug: Roxadustat;   Drug: Epoetin Alfa Sponsor:   Second Xiangya Hospital of Central South University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials